[HTML][HTML] The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells

PW Andrews, I Barbaric, N Benvenisty, JS Draper… - Cell Stem Cell, 2022 - cell.com
It is well established that human pluripotent stem cells (hPSCs) can acquire genetic and
epigenetic changes during culture in vitro. Given the increasing use of hPSCs in research …

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

AS Lee, C Tang, MS Rao, IL Weissman, JC Wu - Nature medicine, 2013 - nature.com
Human pluripotent stem cells (PSCs) are a leading candidate for cell-based therapies
because of their capacity for unlimited self renewal and pluripotent differentiation. These …

A reference human induced pluripotent stem cell line for large-scale collaborative studies

CB Pantazis, A Yang, E Lara, JA McDonough… - Cell stem cell, 2022 - cell.com
Human induced pluripotent stem cell (iPSC) lines are a powerful tool for studying
development and disease, but the considerable phenotypic variation between lines makes it …

The landscape of somatic copy-number alteration across human cancers

R Beroukhim, CH Mermel, D Porter, G Wei… - Nature, 2010 - nature.com
A powerful way to discover key genes with causal roles in oncogenesis is to identify
genomic regions that undergo frequent alteration in human cancers. Here we present high …

Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes

Y Maury, J Côme, RA Piskorowski… - Nature …, 2015 - nature.com
Abstract Specification of cell identity during development depends on exposure of cells to
sequences of extrinsic cues delivered at precise times and concentrations. Identification of …

The tumorigenicity of human embryonic and induced pluripotent stem cells

U Ben-David, N Benvenisty - Nature Reviews Cancer, 2011 - nature.com
The unique abilities of human pluripotent stem cells to self-renew and to differentiate into
cells of the three germ layers make them an invaluable tool for the future of regenerative …

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

K Yusa, ST Rashid, H Strick-Marchand, I Varela, PQ Liu… - Nature, 2011 - nature.com
Human induced pluripotent stem cells (iPSCs) represent a unique opportunity for
regenerative medicine because they offer the prospect of generating unlimited quantities of …

[HTML][HTML] Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture

LC Laurent, I Ulitsky, I Slavin, H Tran, A Schork… - Cell stem cell, 2011 - cell.com
Genomic stability is critical for the clinical use of human embryonic and induced pluripotent
stem cells. We performed high-resolution SNP (single-nucleotide polymorphism) analysis on …

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

K Amps, PW Andrews, G Anyfantis… - Nature …, 2011 - search.ebscohost.com
Abstract The International Stem Cell Initiative analyzed 125 human embryonic stem (ES) cell
lines and 11 induced pluripotent stem (iPS) cell lines, from 38 laboratories worldwide, for …

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells

A Urbach, O Bar-Nur, GQ Daley, N Benvenisty - Cell stem cell, 2010 - cell.com
In embryonic stem cell (ESC) lines generated from human embryos determined through
preimplantation genetic diagnosis to carry the fragile X mutation, the FMR1 gene is …